Natingor, Marylyne B.

HRN: 26-00-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/03/2024
10/10/2024
IV
600mg
Q8h
Infected Breast Mass
Waiting Final Action 
10/03/2024
MUPIROCIN 2%, 15G (TUBE)
10/03/2024
10/10/2024
TOPICAL
Apply On Affected Area
BID
Infected Breast Mass
Waiting Final Action 
10/04/2024
CEFTRIAXONE 1G (VIAL)
10/04/2024
10/10/2024
IV
2g
OD
Infected Breast Mass
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: